1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT

1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT

Denise Albano,1 Thomas Bilfinger,1 Barbara Nemesure2 1Department of Surgery, Health Sciences Center, Stony Brook Medicine, Stony Brook, NY, USA; 2Department of Family, Population and Preventive Medicine, Health Sciences Center, Stony Brook Medicine, Stony Brook, NY, USA Background: Lobectomy has tra...

Full description

Bibliographic Details
Main Authors: Albano D, Bilfinger T, Nemesure B
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Lung Cancer : Targets and Therapy
Subjects:
SBRT
Lobectomy
Survival
Online Access:https://www.dovepress.com/1--3--and-5-year-survival-among-early-stage-lung-cancer-patients-treat-peer-reviewed-article-LCTT

Internet

https://www.dovepress.com/1--3--and-5-year-survival-among-early-stage-lung-cancer-patients-treat-peer-reviewed-article-LCTT

Similar Items